Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
PMCB vs. ETF Alternatives
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This unique and patented technology will be... More
Other News & PR